Pharmacovigilance Expansion UBC recently launched the RxLogix pharmacovigilance reporting platform, signaling a strategic expansion into enhanced drug safety capabilities that can drive demand for comprehensive PV solutions and real-world safety data services.

Evidence and Real-World Data Focus UBC specializes in evidence development and real-world data analytics to demonstrate safety, efficacy, and value under real-world conditions, presenting opportunities to upsell integrated data analytics, outcomes research, and payer-focused evidence generation.

Regulatory and PV Leadership Recognition as a pharmacovigilance leader in Everest Group PV Operations PEAK Matrix positions UBC as a trusted partner for biopharma seeking mature PV operations, offering a basis to pre-emptively approach potential clients on PV optimization projects.

Industry Recognition & Collaborations Past awards and ongoing collaborations (e.g., international infection control award, cross‑industry events) suggest UBC has credibility and network effects that can be leveraged to win partnerships, joint ventures, and multi‑client programs in safety and real-world evidence.

Scale and Enterprise Fit With a large employee base and revenue in the billions, UBC targets large biopharma organizations that require scalable evidence, PV, and data solutions, indicating opportunities for enterprise‑level service contracts and long‑term managed service engagements.